Citation Impact
Citing Papers
Multiplex PCR: Optimization and Application in Diagnostic Virology
2000
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible
2013 StandoutScienceNobel
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
2002
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
2001
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Telomerase regulation and stem cell behaviour
2006
Reactive oxygen species produced by NADPH oxidase regulate plant cell growth
2003 StandoutNature
Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
1996
Cancer risk in patients with inflammatory bowel disease
2001 Standout
Engineering Novel Cell Surface Receptors for Virus-mediated Gene Transfer
1999 StandoutNobel
Epigenetic targets in hematopoietic malignancies
2003
Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes
1998
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
2007
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine
2001
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura
2000
Senescence, apoptosis and therapy — cutting the lifelines of cancer
2003
Single-Cell Profiling Identifies Aberrant STAT5 Activation in Myeloid Malignancies with Specific Clinical and Biologic Correlates
2008
Chronic myelomonocytic leukemia
2002
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
2008
Cellular Senescence in Cancer and Aging
2007 Standout
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS
2001
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Genetic analysis of chemoresistance in primary murine lymphomas
2000
The changing landscape of atherosclerosis
2021 StandoutNature
Myelodysplastic Syndromes
2004
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
A DNA damage checkpoint response in telomere-initiated senescence
2003 StandoutNature
Hypermethylation of tumor suppressor genes in cancer
1999
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53
1999
Mouse models of human AML accurately predict chemotherapy response
2009
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
2002 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In Vivo
2011 StandoutNobel
Immune Thrombocytopenic Purpura
2002 Standout
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
2003
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
TET enzymes, TDG and the dynamics of DNA demethylation
2013 StandoutNature
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
1997 Standout
Apoptosis
2002 Standout
Viruses and tumours – an update
2004
DNA Methylation Inhibitors in the Treatment of Leukemias, Myelodysplastic Syndromes and Hemoglobinopathies: Clinical Results and Possible Mechanisms of Action
2000
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Management of Immune Thrombocytopenic Purpura in Adults
2004
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis
1999
An Alternative Transcript Derived from the Trio Locus Encodes a Guanosine Nucleotide Exchange Factor with Mouse Cell-transforming Potential
2004
Childhood Leukemias
1995
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Clinical implications of p53 mutations
1999
Advances in the diagnosis of idiopathic thrombocytopenic purpura
2000
Interleukin-2: Clinical applications
2002
Configuration of the TP53 Gene as an Independent Prognostic Parameter of Myelodysplastic Syndrome
2003
Genetics of therapy-related myelodysplasia and acute myeloid leukemia
2008
Therapy with azanucleosides for myelodysplastic syndromes
2010
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
2006
A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
2000 StandoutNatureNobel
International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome
2001
The Retinoblastoma Gene (RB-1) Status in Multiple Myeloma: A Report on 35 Cases
1995
Zygomycosis
2002
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Rho GTPases and Regulation of Hematopoietic Stem Cell Localization
2008
Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human Cancer
1996
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
The cancer genome
2009 StandoutNature
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine
2007
Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes
2011
Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole Prophylaxis
2004
bax -deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
1997
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
2002
Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura
2007
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]
1996 Standout
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features
2006
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Cancer Cell Cycles
1996 StandoutScience
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy
2004
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
2009
Cytokine Storm
2020 Standout
Multiple Independent Defective Suppressor-mutator Transposon Insertions in Arabidopsis: A Tool for Functional Genomics
1999
Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
1999
Activation and Differentiation of Autoreactive B-1 Cells by Interleukin 10 Induce Autoimmune Hemolytic Anemia in Fas-deficient Antierythrocyte Immunoglobulin Transgenic Mice
2002 StandoutNobel
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Polycythemia vera: myths, mechanisms, and management
2002
Host Sequences Flanking the Human T-Cell Leukemia Virus Type 1 Provirus In Vivo
2000
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
2000 StandoutScience
Cell cycle deregulation in B-cell lymphomas
2003
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
A Large Proportion of Patients With a Diagnosis of Essential Thrombocythemia Do Not Have a Clonal Disorder and May Be at Lower Risk of Thrombotic Complications
1999
Multiple Myeloma
2011 Standout
Growth Factors, Matrices, and Forces Combine and Control Stem Cells
2009 StandoutScience
Invasive disease due to Mucorales: a case report and review of the literature.
2001
The incidence of secondary leukemias.
1999
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
2007
Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
2005
TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer.
2003
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
2004 StandoutScience
Works of Eric Wattel being referenced
Human T Lymphotropic Virus (HTLV) Type I and II DNA Amplification in HTLV-I/II-Seropositive Blood Donors of the French West Indies
1992
Is there still a role for low-dose cytosine arabinoside in de novo acute myeloid leukemia in the elderly?
1993
Chronic myelomonocytic leukemia: from biology to therapy
1997
Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo
2003
Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients
1993
Low incidence of specific anti‐platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy
1996
Good Predictive Value of Combined Cytogenetic and Molecular Follow Up in Chronic Myelogenous Leukemia After Non T-cell Depleted Allogeneic Bone Marrow Transplantation: A Report on 38 Consecutive Cases
1995
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
2004
Inactivation of hTERT transcription by Tax
2003
Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
1995
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes
1999
Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases
1994
Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation
1999
A randomized trial comparing vinblastine in slow infusion and by bolus i.v. injection in idiopathic thrombocytopenic purpura: a report on 42 patients
1994
Association between myelodysplastic syndromes and inflammatory bowel diseases. Report of seven new cases and review of the literature
1997
Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR
1995
Persistent oligoclonal expansion of human T-cell leukemia virus type 1-infected circulating cells in patients with Tropical spastic paraparesis/HTLV-1 associated myelopathy
1998
Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
1995
Acute Myeloid Leukemia and Myelodysplastic Syndromes Following Essential Thrombocythemia Treated With Hydroxyurea: High Proportion of Cases With 17p Deletion
1998
Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells
1996
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group
1996
Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies.
1996
Methylation of the p15INK4b Gene in Myelodysplastic Syndromes Is Frequent and Acquired During Disease Progression
1998
p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
1994
p16 gene homozygous deletions in acute lymphoblastic leukemia
1995
Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
1993
Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM.
1996
Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
2006
Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy
1995
Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes.
1993